Delivery Order SPE2DB22D3501-SPE2DB23FWP59
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $5,189.52 firm fixed price delivery order by the Defense Logistics Agency to supply 4561431391, Ropivacaine 0.2% 400 mg/200 ml in 200 ml containers. Performance will take place in Conshohocken, Pennsylvania over a period of 3 days from July 7 through July 10, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $4,497.31 firm fixed price delivery order by the Defense Logistics Agency to supply 400 mg/200 ml vials of ropivacaine hydrochloride 0.2% injectable solution. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 10-11, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department...
- The Defense Logistics Agency awarded a $5,061.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml in 200 ml units). This is a non-set-aside competitive award with an ultimate completion date of December 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a relatively modest procurement action within the federal...
- The Defense Logistics Agency awarded a $1,154.95 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 ml) pharmaceutical product, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,162.46 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,050.68 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% 200 mg/100 mL in 100 mL units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. No set-aside designation was used for this procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,685.05 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml format) with a completion date of August 26, 2025. This firm fixed-price delivery order, awarded without set-aside provisions on August 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $4,400.42 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL), a local anesthetic pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a $306 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561682009 Ropivacaine 0.5% 100 MG/20 ML 20ML. The place of performance is Conshohocken, Pennsylvania. The order is for a single day's supply of the specified pharmaceutical to support DLA's medical materiel procurement programs. As the prime, Amerisourcebergen Drug Corporation will fulfill the order without involvement of major subcontractors. The award draws from DLA's...
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWP59Delivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $12,669.85 firm fixed price delivery order by the Defense Logistics Agency to supply 4561610964 Ropivacaine 0.2% 400 mg/200 ml solution in 200 ml containers. Performance will take place in Conshohocken, Pennsylvania over one day from July 26 to July 27, 2023. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle to fulfill agency medical supply needs. No subcontractors or set aside designations were indicated. This award will enable the DLA to maintain critical stock levels of an anesthetic drug used to manage pain for military patients.
Generated 12/24/23, 1:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 7/26/23 |